AB Science Statistics
Total Valuation
AB Science has a market cap or net worth of 126.13 million. The enterprise value is 138.48 million.
| Market Cap | 126.13M |
| Enterprise Value | 138.48M |
Important Dates
The next estimated earnings date is Tuesday, September 30, 2025.
| Earnings Date | Sep 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 59.37M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +7.27% |
| Shares Change (QoQ) | +6.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 23.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 113.65 |
| PB Ratio | -5.13 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 329.27 |
| P/OCF Ratio | 232.05 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.08 |
| EV / Sales | 109.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 361.51 |
Financial Position
The company has a current ratio of 0.71
| Current Ratio | 0.71 |
| Quick Ratio | 0.66 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 49.92 |
| Interest Coverage | -5.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -15.62% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -221.85% |
| Revenue Per Employee | 32,643 |
| Profits Per Employee | -238,455 |
| Employee Count | 39 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.33% in the last 52 weeks. The beta is 1.58, so AB Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.58 |
| 52-Week Price Change | -53.33% |
| 50-Day Moving Average | 9.64 |
| 200-Day Moving Average | 13.26 |
| Relative Strength Index (RSI) | 30.41 |
| Average Volume (20 Days) | 8,476 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AB Science had revenue of 1.11 million and -8.11 million in losses. Loss per share was -0.16.
| Revenue | 1.11M |
| Gross Profit | 1.29M |
| Operating Income | -6.30M |
| Pretax Income | -8.11M |
| Net Income | -8.11M |
| EBITDA | -5.89M |
| EBIT | -6.30M |
| Loss Per Share | -0.16 |
Balance Sheet
The company has 8.27 million in cash and 19.12 million in debt, giving a net cash position of -10.85 million.
| Cash & Cash Equivalents | 8.27M |
| Total Debt | 19.12M |
| Net Cash | -10.85M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -24.59M |
| Book Value Per Share | -0.38 |
| Working Capital | -6.12M |
Cash Flow
In the last 12 months, operating cash flow was 543,535 and capital expenditures -160,472, giving a free cash flow of 383,063.
| Operating Cash Flow | 543,535 |
| Capital Expenditures | -160,472 |
| Free Cash Flow | 383,063 |
| FCF Per Share | n/a |
Margins
| Gross Margin | 116.42% |
| Operating Margin | -567.44% |
| Pretax Margin | -730.50% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 34.51% |
Dividends & Yields
AB Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.27% |
| Shareholder Yield | n/a |
| Earnings Yield | -6.43% |
| FCF Yield | 0.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |